1.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000577505, UPCC-01407, UPCC-IRB-806149, NCT00568880
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 21 and over Sponsor: Other Protocol IDs: NS 01/03/08, 2008/00196, NCT00809237
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 19 and over Sponsor: NCI, Other Protocol IDs: UPCI 09-122, PO1101944, NCT01128296
|
|
4.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UPCC 07210, NCT01206530
|
|
5.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UPCC 19211, NCT01506973
|
|
6.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UPCC 07811, NCT01510119
|
|
7.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UPCI 11-080, NCT01550367
|
|
8.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000600326, P30CA072720, CINJ-080803, 080803, NCT00726596
|
|
9.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 070806, CINJ-070806, NCT01006369
|
|
10.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 09-097, OSI4620s, NCT00977470
|
|
11.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CDR0000686729, CRUK-H135, ISRCTN-61568166, EUDRACT-2009-014373-41, EU-21078, CRUK-H135-CHOICES, CHOICES, NCT01227135
|
|
12.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 10-310, NCT01273805
|
|
13.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: UMCNONCO201004, NCT01292408
|
|
14.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11-073, NCT01494155
|
|
15.
|
Phase: Phase II Type: Treatment Status: Approved-not yet active Age: 70 and over Sponsor: Other Protocol IDs: UCL11/0404, NCT01602588
|
|
16.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 031105, 0220110249, P30CA072720, NCT01649947
|
|
17.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000600329, UPCC-12907, NCT00714181
|
|
18.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 050909, U01CA132194, CDR0000630334, 0220090238, CTEP #8342, CINJ-050801, 050801, 0220080281, NCT00813423
|
|
19.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000643294, UPCC-08908, 807931, WYETH-C-UPCC-03809, NCT00909831
|
|
20.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 19 and over Sponsor: NCI, Other Protocol IDs: UPCI 10-029, NCT01144169
|
|
21.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2010-0588, NCT01266057
|
|
22.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: MCC-13713, NCI-2011-02310, P30CA016059, NCT01417403
|
|
23.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CINJ-051105, 051105, 8983, NCT01480154
|
|
24.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CTRC 11-71, HSC20120203H, NCT01634893
|
|
25.
|
Phase: Phase I Type: Treatment Status: Approved-not yet active Age: 18 to 85 Sponsor: NHLBI, Other Protocol IDs: SAIL-1100, NCT01687179
|